Search

Your search keyword '"Salagianni M"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Salagianni M" Remove constraint Author: "Salagianni M"
36 results on '"Salagianni M"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

3. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

9. Rationale for the application of RANKL inhibition in the treatment of langerhans cell histiocytosis

10. Toll-like receptor 7 protects from atherosclerosis by constraining inflammatory macrophage activation

11. Poster Session 3: Friday 9 December 2011, 08:30-12:30 * Location: Poster Area

14. Poster session Friday 13 December - PM: 13/12/2013, 14:00-18:00 * Location: Poster area

15. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

16. Vaginal Microbiome and Pregnancy Complications: A Review.

17. Notch signaling in adipose tissue macrophages prevents diet-induced inflammation and metabolic dysregulation.

18. Comprehensive Analysis of 1-Year-Old Female Apolipoprotein E-Deficient Mice Reveals Advanced Atherosclerosis with Vulnerable Plaque Characteristics.

19. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.

20. Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice.

21. CD103 integrin identifies a high IL-10-producing FoxP3 + regulatory T-cell population suppressing allergic airway inflammation.

22. Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results.

23. Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infections.

24. A Multimodal Approach for the Risk Prediction of Intensive Care and Mortality in Patients with COVID-19.

25. CD8+ T cells in beige adipogenesis and energy homeostasis.

26. Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.

27. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis.

28. New insights into the role of NK cells in cancer immunotherapy.

29. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.

30. Induction of potent CD4+ T cell-mediated antitumor responses by a helper HER-2/neu peptide linked to the Ii-Key moiety of the invariant chain.

31. Cell culture medium composition and translational adult bone marrow-derived stem cell research.

32. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.

33. Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes.

34. Beneficial effect of short-term exposure of human NK cells to IL15/IL12 and IL15/IL18 on cell apoptosis and function.

35. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.

36. Anti-CD3 sFv/IL-18 fusion DNA for allergy therapy.

Catalog

Books, media, physical & digital resources